Radiation and immunotherapy before surgery for oral cancer
Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.
This trial tests combining radiation therapy with immunotherapy and chemotherapy before surgery for advanced oral or throat cancer. The goal is to see if this approach can shrink the tumor and improve treatment outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have squamous cell carcinoma of the mouth or throat.
- Your cancer is stage III or IVa (advanced, but has not spread to distant organs).
- You are between 18 and 70 years old.
- You are in good physical health (ECOG 0 or 1).
- You have not had prior treatment with certain immunotherapies (anti-PD-1, anti-PD-L1, or anti-CTLA-4).
- You do not have active autoimmune diseases, active tuberculosis, or serious mental illness.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if giving a short course of radiation (SBRT) along with chemotherapy and an immunotherapy drug before surgery can improve outcomes for people with advanced mouth or throat cancer that is not caused by HPV. It's designed for patients whose tumors can be surgically removed and who haven't had prior cancer treatment.
This trial tests whether adding targeted radiation (SBRT) to a combination of chemotherapy and immunotherapy before surgery can improve outcomes for people with advanced mouth or throat cancer. It aims to shrink the tumor more effectively before removal.
This trial tests a new immunotherapy drug (tirellizumab) combined with chemotherapy before surgery for early-stage oral cancer. It aims to see if this combination can help shrink the tumor and improve outcomes.
This trial tests whether combining radiation therapy with immunotherapy works better than immunotherapy alone for advanced head and neck cancer that hasn't been treated before. The goal is to help your body's immune system fight the cancer more effectively.
This trial compares two approaches after initial treatment: radiation therapy versus an immunotherapy drug (PD-1 inhibitor) to see which better prevents cancer from coming back. It is for people with advanced oral or throat cancer who have already completed chemoimmunotherapy and surgery to remove all visible cancer.
This trial tests adding targeted radiation before standard immunotherapy and chemotherapy for people with stage 2-3 non-small cell lung cancer that can be surgically removed. The goal is to see if the radiation helps shrink the tumor more before surgery.
Hear when a new SBRT trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.